NLRP3 and Hyperglycemia: Hyperglycemia-induced ROS production may stimulate NLRP3 inflammasome activity through different pathways, including thioredoxin (TRX1)-TXNIP dissociation and accumulation of AGEs and advanced lipoxidation endproducts (ALEs) [139].